SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000893220-07-001237
Filing Date
2007-04-05
Accepted
2007-04-05 15:28:05
Documents
4
Period of Report
2007-05-10
Effectiveness Date
2007-04-05

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT w32942def14a.htm DEF 14A 308570
2 GRAPHIC w32942w3294201.gif GRAPHIC 1901
3 GRAPHIC w32942w3294202.gif GRAPHIC 928
4 GRAPHIC w32942w3294203.gif GRAPHIC 12215
  Complete submission text file 0000893220-07-001237.txt   331511
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32302 | Film No.: 07751832
SIC: 3841 Surgical & Medical Instruments & Apparatus